In the lineup of anti-tumor immune players, γδ T cells often serve as a proxy for CD8 and NK cells, as well as other immune effector subsets known for HLA signaling defects that perturb the APC function, CD8, and NK cell modulation (159, 160). This evidence concerns the gene CD8A and neoplasm.